College of Pharmacy Welcomes Corneliu Bolbocean, Ph.D.

By Benjamin Waldrum

Bolbocean, an accomplished researcher and economist, most recently worked at Oxford University in England, where he was a senior researcher in health economics. He is the recipient of Early Career Researcher Best Paper Prize 2023 at the International Health Economics Association’s 15th World Congress on Health Economics in Cape Town, South Africa.

“We are so excited to welcome Dr. Bolbocean to our division and department,” said Amy Franks, Pharm.D., the department’s chair. “He brings a wealth of experience and research skills that complement the expertise of faculty both in the department and external to the College of Pharmacy, and he is eager to establish a strong research program at UAMS.”

“Dr. Bolbocean made a name for himself at Oxford University as a health economist focused on the intersection of quality of life, machine learning and health care delivery,” said Jacob Painter, Pharm.D., MBA, Ph.D., the division’s director. “We are confident that his expertise will be a significant asset in helping us reach our Vision 2029 goals.”

The College of Pharmacy’s Pharmaceutical Evaluation and Policy graduate program trains future researchers to evaluate the safety, effectiveness and cost of pharmaceutical products and health services.

“I am delighted to join the UAMS College of Pharmacy,” said Bolbocean. “I am happy to work with our pharmacy faculty and students to advance the field of health economics research.”

Bolbocean received his Ph.D. in economics from Simon Fraser University in Burnaby, British Columbia. His research focuses on methodological issues related to quality of life outcomes, children’s health and well-being, economic evaluations of health care interventions. He has previously held positions at the University of Tennessee Health Science Center in Memphis, Tennessee; the Centre for Addiction and Mental Health in Toronto, Canada; BC Children’s Hospital in Vancouver, British Columbia; and at Baylor University in Waco, Texas.